Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?

Transfusion

Volumn 41, Issue 1, 2001, Pages 106-110

  De La Rubia, Javier ^a   Arriaga, Francisco ^a   Andreu, Rafael ^a   Sanz, Guillermo ^a   Jiménez, Carmen ^a   Vicente, Ana ^a   Carpio, Nelly ^a   Marty, María L ^a   Sanz, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CYCLOSPORIN A; ERYTHROCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE; RHESUS D ANTIBODY;

ADOLESCENT; ADULT; AGE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; CHILD; DISEASE PREDISPOSITION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; STATISTICAL ANALYSIS;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGING; ANTIBODY SPECIFICITY; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035126275     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41010106.x     Document Type: Article

References (27)

1. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s
2. Bone marrow transplantation
3. How does bone-marrow transplantation cure leukaemia?
4. Immunohematologic complications of bone marrow transplantation
5. Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature
6. Red cell antibodies produced after bone marrow transplantation
7. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients
8. Transplantation of ABH incompatible bone marrow: Gravity sedimentation of donor bone marrow
9. Safety of the antibody screening test as the sole method of pretransfusion testing
10. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant
11. A new elution procedure using a nonflammable organic solvent
12. Optimal conditions for the use of sulphydryl compounds in dissociating red cell antibodies
13. Hemolysis associated with transplantation
14. Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia
15. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation
16. Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation
17. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation
18. Cyclosporine
19. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation
20. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate
21. The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation
22. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases
23. Red cell alloantibody development associated with heart and lung transplantation
24. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation
25. Bone marrow transplantation in patients aged 45 years and older